EUVIMEDEUVIMED entdecken
Crossref

Octreotide-modified pH-responsive nanocomposites for ultrasound imaging-guided chemo-photothermal therapy of prostate cancer

Ran Sun, Qian Liu, Yang Guo, Hua Hong, Zhanzhong Wang, Changsong Dai, Zhaohui Wen

Nanoscale · 2026 · 18 (43) · 23877-23902

DOI: 10.1039/d6nr02110g ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2026. Verfasst von Ran Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Brain Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China. wenzhaohui1968@163.com. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Nanocomposites, Octreotide, Photothermal Therapy. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer remains a major malignancy in men, and its clinical management is still limited by insufficient tumor-specific imaging, inefficient drug delivery, and suboptimal therapeutic efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsNanocompositesOctreotidePhotothermal TherapyMaleHumansAnimalsHydrogen-Ion ConcentrationMiceMice, NudeDoxorubicinUltrasonographyCell Line, TumorPC-3 Cells

Substanzen

OctreotideDoxorubicin

Autor:innen und Institutionen

  • Department of Neurology, Brain Ultrasound, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China. wenzhaohui1968@163.com.
  • Department of Ultrasound Medicine, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, China.
  • Department of Nuclear Medicine, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, China.
  • MIIT Key Laboratory of Critical Materials Technology for New Energy Conversion and Storage, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin 150001, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, R., Liu, Q., Guo, Y., Hong, H., Wang, Z., Dai, C., & Wen, Z. (2026). Octreotide-modified pH-responsive nanocomposites for ultrasound imaging-guided chemo-photothermal therapy of prostate cancer. Nanoscale, 18(43), 23877-23902. https://doi.org/10.1039/d6nr02110g

Vancouver

Sun R, Liu Q, Guo Y, Hong H, Wang Z, Dai C, et al. Octreotide-modified pH-responsive nanocomposites for ultrasound imaging-guided chemo-photothermal therapy of prostate cancer. Nanoscale. 2026;18(43):23877-23902. doi:10.1039/d6nr02110g

BibTeX
@article{Sun2026,
  author = {Sun, Ran and Liu, Qian and Guo, Yang and Hong, Hua and Wang, Zhanzhong and Dai, Changsong and Wen, Zhaohui},
  title = {Octreotide-modified pH-responsive nanocomposites for ultrasound imaging-guided chemo-photothermal therapy of prostate cancer},
  journal = {Nanoscale},
  year = {2026},
  volume = {18},
  number = {43},
  pages = {23877--23902},
  doi = {10.1039/d6nr02110g}
}
Kostenlos starten →